Responsibilities
1. Participate in the development of clinical strategies and plans for new drugs and be responsible for the medical evaluation of clinical protocols, including clinical feasibility and potential risk analysis; support clinical study design, including the selection of therapeutic areas, target populations, treatment regimens, and control groups.
2. Interact with investigators and regulatory authorities during the clinical application phase of new drugs to discuss clinical development plans.
3. Responsible for the development of clinical trial materials (investigator manual, trial protocol, informed consent form, case report form, subject diary, etc.).
4. Interact with investigators during the clinical operations phase to provide information on investigational drugs and ongoing assessment of medical effectiveness and safety.
5. Provide medical support during the clinical operations phase, including review of protocol violations and operational consistency to ensure medical compliance with the protocol, responsible for review and interpretation of clinical data, and communicate with the study site and related parties regarding relevant medical issues in the EDC system to resolve queries.
6. Conduct medical assessments of individual subjects, including inclusion/exclusion criteria, adverse events/serious adverse events, medical history, concomitant medications, laboratory tests, etc., and provide summaries of necessary information to provide a basis for decision making by the project team and investigators.
7. Be responsible for relevance determination of adverse events, provide clarification or confirmation to investigators on relevant issues, and be responsible for relevance assessment.
8. File and update safety reports (DSUR) during R&D.
9. Be responsible for researching and summarizing the clinical data of similar varieties at home and abroad.